Neurosoft Bioelectronics

Stub active Updated May 26, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Geneva, Switzerland (US subsidiary: New York, NY)
Founded 2019
Latest Stage Seed
Total Raised $20M+
Website https://www.neurosoft.bio
Sector
neurotech brain-computer-interface medical-devices healthcare neuroscience

About

Neurosoft Bioelectronics is a neurotechnology company developing stretchable and scalable brain-computer interfaces, with headquarters in Geneva, Switzerland and a US subsidiary in New York 1. The company is advancing clinical trials across both the United States and Europe, with near-term milestones focused on demonstrating minimally invasive deployment in human patients and achieving US commercialization of its first brain interface 1 2. The oversubscribed seed round brings Neurosoft’s total funding raised to date to more than $20 million 1.

Funding History

Date Round Amount Lead Co-investors
2026-05-20 Seed (oversubscribed) $7.5M Skybound Venture Capital PL Capital, IAG Capital Partners, Connecticut Innovations 1 2

What Investors Say

No independently sourced investor commentary found at this time beyond press-release boilerplate.

What Founders Say

No independently sourced founder testimonials found at this time.

Sources

  1. Business Wire, “Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round to Build Stretchable and Scalable Brain-Computer Interfaces,” May 20, 2026, accessed May 2026. https://www.businesswire.com/news/home/20260520357988/en/Neurosoft-Bioelectronics-Closes-$7.5M-Oversubscribed-Seed-Round-to-Build-Stretchable-and-Scalable-Brain-Computer-Interfaces↩↩↩↩

  2. Tech Startups, “Swiss neurotech startup Neurosoft raises $7.5M to build AI-powered stretchable brain-computer interfaces,” May 20, 2026, accessed May 2026. https://techstartups.com/2026/05/20/swiss-neurotech-startup-neurosoft-raises-7-5m-to-build-ai-powered-stretchable-brain-computer-interfaces/↩↩